ACVRL1 belongs to the family of TGF-β I receptors, and its abnormal changes significantly affect the regulation of the TGF-β pathway, contributing to the development of pulmonary hypertension (51, 52). This evidence concerns the gene ACVRL1 and pulmonary arterial hypertension.